I have followed biotech stocks exclusively for many years and while I've had my share of disappointments (e.g., IPIC), I like to think that my handicapping skills are quite honed. (Can't say the same thing about my money management though!)
I haven't posted a message on a Yahoo stock board in months, but I just wanted to lend a new voice to the debate by stating that I think SUPG at these levels is the single best biotech buying opportunity I've seen since SEPR's early years (sold that one way too early - twice). I don't have any new info on the company to add, but the data is published -as are the sales numbers for Gemzar -, Joe R's track record is established, and SUPG's pipeline, healthy balance sheet and committment to the shareholder's is also a matter of record (e.g,. latest CC, stock re-purchase program). As an aside, I am curious when, if ever, management will pull the trigger and start to re-purchase stock. Given the drop in price, let them buy back 1.5m shares now!
Just standing up and being counted. Much to my chagrin and financial ill health, I've learned that there is no sure thing in biotech - ever. However, I stand by my statement that SUPG today is the single best buy in the biotech area of the past several years. And I bought some today.